Citation Impact
Citing Papers
Oxidative Stress
2017 Standout
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Mammalian Transient Receptor Potential TRPA1 Channels: From Structure to Disease
2019
Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
2011 Standout
Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
Effect of High-Dose Vitamin D 3 on Hospital Length of Stay in Critically Ill Patients With Vitamin D Deficiency
2014
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
2023 Standout
Cancer immunotherapy beyond immune checkpoint inhibitors
2018
Osteoarthritis year in review 2019: epidemiology and therapy
2020 Standout
Glutamatergic transmission in the trigeminal nucleus assessed with local blood flow
2000
Methods for evaluation of platelet function
2009 StandoutNobel
Genetic modulation of the pharmacological treatment of pain
2009
A placebo‐controlled study examining the effect of allopurinol on heart rate variability and dysrhythmia counts in chronic heart failure
2001
Omarigliptin: First Global Approval
2015
NeuPSIG guidelines on neuropathic pain assessment
2010 Standout
Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications
2011 Standout
The pharmacology of headache
2000
Quantification of cerebral cannabinoid receptors subtype 1 (CB1) in healthy subjects and schizophrenia by the novel PET radioligand [11C]OMAR
2010
Bisphenol A and human health: A review of the literature
2013 Standout
Neural mechanism underlying acupuncture analgesia
2008 Standout
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
2006 Standout
Descending control of pain
2002 Standout
ESPEN guideline on clinical nutrition in the intensive care unit
2018 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
2007 Standout
Increasing the oral bioavailability of the poorly water soluble drug itraconazole with ordered mesoporous silica
2007
Irritant-evoked activation and calcium modulation of the TRPA1 receptor
2020 StandoutNatureNobel
Mechanical, thermal and formalin-induced nociception is differentially altered in 5-HT1A−/−, 5-HT1B−/−, 5-HT2A−/−, 5-HT3A−/− and 5-HTT−/− knock-out male mice
2007 StandoutNobel
Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs
2013
Locomotor networks are targets of modulation by sensory transient receptor potential vanilloid 1 and transient receptor potential melastatin 8 channels
2009 StandoutNobel
Aprepitant in adolescent patients for prevention of chemotherapy‐induced nausea and vomiting: A randomized, double‐blind, placebo‐controlled study of efficacy and tolerability
2008
Acute effects of sumatriptan on aortic blood pressure, stiffness, and pressure waveform
2006
Triptans in Migraine
2000
Characterization of platelet dysfunction after trauma
2012
Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2013
Pituitary adenylate cyclase-activating polypeptide plays a key role in nitroglycerol-induced trigeminovascular activation in mice
2011
Fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting
2012
Advances in the Pharmacotherapy of Migraine
1999
UPLC-MS-MS Method for Simultaneous Determination of Caffeine, Tolbutamide, Metoprolol, and Dapsone in Rat Plasma and its Application to Cytochrome P450 Activity Study in Rats
2012
Pharmacological and expression profile of the prostaglandin I2 receptor in the rat craniovascular system
2011
CGRP blockade by galcanezumab was not associated with reductions in signs and symptoms of knee osteoarthritis in a randomized clinical trial
2018
The role of the posterior cingulate cortex in cognition and disease
2013 Standout
How to improve R&D productivity: the pharmaceutical industry's grand challenge
2010 Standout
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Calcitonin Gene–Related Peptide Receptor Antagonist BIBN 4096 BS for the Acute Treatment of Migraine
2004 Standout
The anti‐migraine 5‐HT1B/1D agonist rizatriptan inhibits neurogenic dural vasodilation in anaesthetized guinea‐pigs
2001
Prevention of Preeclampsia and Intrauterine Growth Restriction With Aspirin Started in Early Pregnancy
2010 Standout
A novel modification of the Thrombelastograph assay, isolating platelet function, correlates with optical platelet aggregation
2004
Evidence for serotonin (5-HT)1B, 5-HT1D and 5-HT1F receptor inhibitory effects on trigeminal neurons with craniovascular input
2003
Chemotherapy-Induced Nausea and Vomiting
2008 Standout
Prevalence and Burden of Migraine in the United States: Data From the American Migraine Study II
2001 Standout
Migraine — Current Understanding and Treatment
2002 Standout
Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery
2012 Standout
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
2016 Standout
Changes in Cerebral CB1Receptor Availability after Acute and Chronic Alcohol Abuse and Monitored Abstinence
2014
Therapeutic Effects of Xanthine Oxidase Inhibitors: Renaissance Half a Century after the Discovery of Allopurinol
2006 Standout
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2019 Standout
Tachykinin receptor antagonists in clinical trials
2009
The Transcriptional Regulation of the Human CYP2C Genes
2009
Critical evaluation of key evidence on the human health hazards of exposure to bisphenol A
2011
Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study
2014
Bisphenol A levels in blood depend on age and exposure
2009
Development of therapeutic antibodies for the treatment of diseases
2020 Standout
Non-specific low back pain
2011 Standout
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Low-dose ASA Response Using the PFA-100 in Women With High-risk Pregnancy
2009
Fingertip photoplethysmography and migraine
2003
Photoplethysmography and its application in clinical physiological measurement
2007 Standout
Randomized, Controlled Study of Telcagepant in Patients With Migraine and Coronary Artery Disease
2012
Chronic daily headache
2000
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia
2017 Standout
CGRP and its receptors provide new insights into migraine pathophysiology
2010
Ischemic Stroke Associated With Calcitonin Gene-Related Peptide Inhibitor Therapy for Migraine: A Case Report
2019
IMAGING STUDY: Prefrontal cortex morphometry in abstinent adolescent marijuana users: subtle gender effects
2009
Neurobiology of addiction: a neurocircuitry analysis
2016 Standout
Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial
2016
Driving earlier clinical attrition: if you want to find the needle, burn down the haystack. Considerations for biomarker development
2007
Reactive Oxygen-Related Diseases: Therapeutic Targets and Emerging Clinical Indications
2015
Pharmacology and Clinical Drug Candidates in Redox Medicine
2015
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Randomized controlled trial of the orexin receptor antagonist filorexant for migraine prophylaxis
2014
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Magnesium in Man: Implications for Health and Disease
2014 Standout
The Hitchhiker’s Guide to Flow Chemistry
2017 Standout
The Therapeutic Potential of Apigenin
2019 Standout
Peripheral and central nervous system distribution of the CGRP neutralizing antibody [125I] galcanezumab in male rats
2019
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Neuropathic Pain: From Mechanisms to Treatment
2020 Standout
Periaqueductal gray calcitonin gene-related peptide modulates trigeminovascular neurons
2015
The role of calcitonin gene–related peptide in peripheral and central pain mechanisms including migraine
2017
Pharmaceuticals of Emerging Concern in Aquatic Systems: Chemistry, Occurrence, Effects, and Removal Methods
2019 Standout
Calcitonin Gene‐Related Peptide ( CGRP ) and Migraine Current Understanding and State of Development
2013
Lack of efficacy of the selective iNOS inhibitor GW274150 in prophylaxis of migraine headache
2010
New Appendix Criteria Open for a Broader Concept of Chronic Migraine
2006 Standout
Cardiovascular and hemodynamic parameters in women following prolonged CGRP inhibition using LBR-101, a monoclonal antibody against CGRP
2014
Plastic and Human Health: A Micro Issue?
2017 Standout
Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine
2011
Calcitonin-gene-related peptide pathway mAbs and migraine prevention
2018
Randomized trial of AT-1015 for treatment of intermittent claudication. A novel 5-hydroxytryptamine antagonist with no evidence of efficacy
2004
2020 International Society of Hypertension Global Hypertension Practice Guidelines
2020 Standout
Discrepancy between strong cephalic arterial dilatation and mild headache caused by prostaglandin D2(PGD2)
2010
Calcitonin Gene-Related Peptide: Physiology and Pathophysiology
2014
Works of Jan de Hoon being referenced
Acute vascular effects of dihydroergotamine in man
1999
Calcitonin gene-related peptide induces vasodilation by nitric oxide
1999
Blockade of Capsaicin-Induced Dermal Vasodilatation (CIDV) by MK-3207, a Calcitonin-Gene Related Peptide (CGRP) Receptor Antagonist for Acute Treatment of Migraine
2009
Comparison of the vascular effects of selective 5-HT1B/1D receptor agonists in migraine patients.
2000
Characterizing the Relationship Between AMG 334 Concentration and Capsaicin-Induced Increase in Dermal Blood Flow in Healthy Subjects and Migraine Patients Using Pharmacokinetic-Pharmacodynamic Modeling
2015
Calcitonin gene-related peptide induced vasodilation depends on the release of nitric oxide
1999
MK-0974, a novel oral CGRP antagonist, exhibits similar pharmacokinetics during and between migraine attacks
2007
二重オレキシン受容体アンタゴニスト,スボレキサント(MK-4305)の健常男性対象者における単回投与による薬物動態的および薬力学的プロファイル
2011
PET imaging in healthy subjects and migraineurs suggests CGRP receptor antagonists do not have to act centrally to achieve clinical efficacy
2013
Mini-series: II. Clinical aspects. Clinically relevant CYP450-mediated drug interactions in the ICU
2009
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the CGRP Binding Monoclonal Antibody LY2951742 (Galcanezumab) in Healthy Volunteers
2017
Substantial Variation in Transplacental Transfer of Chemotherapeutic Agents in a Mouse Model
2010
Potential mechanisms of prospective antimigraine drugs: A focus on vascular (side) effects
2010
Clinical study of solid dispersions of itraconazole prepared by hot-stage extrusion
2005
The effect of MK-0524, a prostaglandin D2 receptor antagonist, on prostaglandin D2-induced nasal airway obstruction in healthy volunteers
2007
Effect of aprepitant on the pharmacokinetics and pharmacodynamics of warfarin
2005
Pharmacokinetic-Pharmacodynamic Relationship of Erenumab (AMG 334) and Capsaicin-Induced Dermal Blood Flow in Healthy and Migraine Subjects
2017
Does the Unfavorable Pharmacokinetic and Pharmacodynamic Profile of the iNOS Inhibitor GW273629 Lead to Inefficacy in Acute Migraine?
2009
Calcitonin Gene-Related Peptide8-37 Antagonizes Capsaicin-Induced Vasodilation in the Skin: Evaluation of a Human in Vivo Pharmacodynamic Model
2008
Tramadol disposition in the very young: an attempt to assess in vivo cytochrome P -450 2D6 activity
2005
Transplacental transfer of anthracyclines, vinblastine, and 4-hydroxy-cyclophosphamide in a baboon model
2010
Gender-dependent increases with healthy aging of the human cerebral cannabinoid-type 1 receptor binding using [18F]MK-9470 PET
2007
Translational Pharmacodynamics of Calcitonin Gene-Related Peptide Monoclonal Antibody LY2951742 in a Capsaicin-Induced Dermal Blood Flow Model
2015
Pharmacokinetics of chemotherapeutic agents in pregnancy: a preclinical and clinical study
2010
A randomized clinical trial comparing point-of-care platelet function assays and bleeding time in healthy subjects treated with aspirin or clopidogrel
2011
Effects of enteric‐coated, low‐dose aspirin on parameters of platelet function
2002
The potent calcitonin gene‐related peptide receptor antagonist, telcagepant, does not affect nitroglycerin‐induced vasodilation in healthy men
2010
Covariates of tramadol disposition in the first months of life
2008
Postmenstrual Age and CYP2D6 Polymorphisms Determine Tramadol O-demethylation in Critically Ill Neonates and Infants
2008
Relationship of Type 1 Cannabinoid Receptor Availability in the Human Brain to Novelty-Seeking Temperament
2009
Both postnatal and postmenstrual age contribute to the interindividual variability in tramadol glucuronidation in neonates
2007
Development of an in vivo target‐engagement biomarker for TRPA1 antagonists in humans
2016
Pharmacokinetics and Pharmacodynamics of Omarigliptin, a Once‐Weekly Dipeptidyl Peptidase‐4 (DPP‐4) Inhibitor, After Single and Multiple Doses in Healthy Subjects
2016
PET imaging in healthy subjects and migraineurs suggests CGRP receptor antagonists do not have to act centrally to achieve clinical efficacy
2013
GCT1021-01, a first-in-human, open-label, dose-escalation trial with expansion cohorts to evaluate safety of Axl-specific antibody-drug conjugate (HuMax-Axl-ADC) in patients with solid tumors (NCT02988817).
2017
Non-invasive assessment of selective 5-HT 1B/1D -receptor agonist-induced peripheral vascular effects in humans: comparison of different techniques
2002
Phase I, Randomized, Double‐blind, Placebo‐controlled, Single‐dose, and Multiple‐dose Studies of Erenumab in Healthy Subjects and Patients With Migraine
2017